Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Olera is a health and wellness services provider that connects caregivers to service providers in the eldercare industry.
Akava Therapeutics is a small molecule therapeutics that inhibits protein aggregation, enzymes, and cancer for neurodegenerative diseases.
EydisBio is the operator of a biotech platform dedicated to developing medical solutions for cancer and arthritis.
Constantiam Biosciences is the resource for functional evidence in clinical genetics.
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.
Piccolo Medical is a medical device company.
Amptify is an ecosystem of hearing health built to improve the provider and patient experience through comprehensive tech-enhanced care.
Evon Medics, LLC is focused on developing and delivering breakthrough therapeutics and devices to address brain-related conditions.
Sonde Health is a digital medicine company.
EIP Pharma is a clinical stage therapeutics company developing drugs to treat neurodegenerative diseases.
VivoSense is an advancing clinical research with wearable sensor solutions.
This company is provides cutting edge analysis of brain images to enable disease diagnosis.
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
Blue Marble Health is telehealth and remote therapeutic monitoring platform for aging and chronic disease management.
Tulane University Brain Institute focus on understanding why estrogen therapy helps protect some women from age-related brain problems.
The leading digital therapeutic and community for Alzheimer’s and cognitive health
Cleveland Alzheimer's Disease Research Center is the multi-institutional Alzheimer research center.
National Institute on Aging has invested in 65 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institute on Aging's top investment sectors include Health Care, Biotechnology, Therapeutics, Wellness, Medical. The firm invests across 25 different industry categories.
Among tracked funding rounds, EIP Pharma received $21.0M in a Grant round. National Institute on Aging's total known invested capital is $400.3M.
National Institute on Aging's average investment size is $7.4M across its portfolio of 65 companies.
Recent National Institute on Aging portfolio additions include Olera, Akava Therapeutics, EydisBio, Constantiam Biosciences, Bolden Therapeutics. These companies were founded in 2020 or later.